115. 遺伝性周期性四肢麻痺 Hereditary periodic paralysis Clinical trials / Disease details


臨床試験数 : 1 薬物数 : 2 - (DrugBank : 2) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 7

  
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00839501
(ClinicalTrials.gov)
December 20085/2/2009Effect of Potassium and Acetazolamide on People With Andersen-Tawil SyndromeTherapeutic Trial of Potassium and Acetazolamide in Andersen-Tawil SyndromeAndersen-Tawil SyndromeDietary Supplement: Potassium;Drug: AcetazolamideUniversity of RochesterOffice of Rare Diseases (ORD);Rare Diseases Clinical Research Network;National Institute of Neurological Disorders and Stroke (NINDS)Terminated10 YearsN/ABoth3Phase 1United States;United Kingdom